Commending GA#467 "Affordable Transgender Hormone Therapy" and the rights it affords transgender individuals regarding their medical transition.
Acknowledging that the recent passage of GA#571 ""Access to Transgender Hormone Therapy" effectively acts a replacement for GA#467, rendering these provisions redundant:
- Understanding that the primary objective of the target, to provide affordable hormone therapy to transgender individuals, is achieved with greater effect by the replacement which mandates "hormone therapy cost no more than the fees absolutely necessary for the manufacturing and distribution".
- Asserting that GA#571 offers a more complete and inclusive definition of "hormone therapy".
- Believing that GA#571 provides more comprehensive protections regarding access to hormone therapy.
- Clarifying that protections against the denial of hormone therapy as a form of punishment are strengthened by GA#571, which forbids any entity from denying hormone therapy "except where a legitimate danger to their health would arise as a result".
- Acknowledging that GA#571 effectively outlaws individuals being required to take, or coerced into taking, hormone therapy against their will.
Believing there is no reason to retain redundant legislation.
Hereby repeals GA#467 "Affordable Transgender Hormone Therapy".
Previous draft:








